The document is an executive summary for Biosys Capital Partners, LP, a venture capital fund focused on investments in technology and life sciences. It outlines the fund's offering, size, capital commitments, investment committee, advisor, investment period, key persons, and terms for removal of the general partner and early termination. The fund seeks $150 million in capital commitments, with a minimum investment of $10 million. The investment committee includes Boris Nikolic, David Schwarz, Peter Corsell, and Hayes Nuss. The document emphasizes confidentiality and is intended for prospective investors.
documents/EFTA01196226.pdf
{}